Table 2.
Renal function at month 6 assessed by estimated GFR (mL/min/1.73 m2) according to Nankivell formula.
Population | Low-dose Tac group (Group A) |
Standard-dose Tac group (Group B) |
Treatment difference (A−B) |
---|---|---|---|
ITT population | n = 145 | n = 137 | |
Mean GFR | 63.6 | 61.0 | 2.6 |
95% CI | 58.8–68.4 | 56.2–65.9 | −2.6–7.8 |
P value1 | 0.326 | ||
| |||
Observed-Cases2 | n = 117 | n = 111 | |
Mean GFR | 69.5 | 65.4 | 4.2 |
95% CI | 65.1–73.9 | 61.0–69.7 | −0.5–8.8 |
P value1 | 0.079 | ||
| |||
“As per Tac level” | n = 853 | n = 693 | |
Mean GFR | 69.9 | 63.2 | 6.6 |
95% CI | 63.1–76.6 | 56.0–70.4 | 0.4–12.9 |
P value1 | 0.038 |
CI: confidence interval, GFR: glomerular filtration rate.
1For A versus B (two-sided).
2ITT population without imputation for missing data.
3“reclassified” Group: defined as >50% of Tac levels (mandatory requirement for Month 6 assessment) being within the protocol-specified Tac target range.